Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Mesenchymal Stem Cells in the Musculoskeletal System: From Animal Models to Human Tissue Regeneration?

Čamernik K, Barlič A, Drobnič M, Marc J, Jeras M, Zupan J.

Stem Cell Rev Rep. 2018 Jun;14(3):346-369. doi: 10.1007/s12015-018-9800-6. Review.

PMID:
29556896
2.

Testing the potency of anti-TNF-α and anti-IL-1β drugs using spheroid cultures of human osteoarthritic chondrocytes and donor-matched chondrogenically differentiated mesenchymal stem cells.

Žigon-Branc S, Barlič A, Knežević M, Jeras M, Vunjak-Novakovic G.

Biotechnol Prog. 2018 Jul;34(4):1045-1058. doi: 10.1002/btpr.2629. Epub 2018 Mar 31.

3.

Applicability of human osteoarthritic chondrocytes for in vitro efficacy testing of anti-TNFα drugs.

Žigon-Branc S, Jeras M, Blejec A, Barlič A.

Biologicals. 2017 Jan;45:96-101. doi: 10.1016/j.biologicals.2016.09.013. Epub 2016 Oct 20.

PMID:
27773423
4.

In vitro impact of bisphenols BPA, BPF, BPAF and 17β-estradiol (E2) on human monocyte-derived dendritic cell generation, maturation and function.

Švajger U, Dolenc MS, Jeras M.

Int Immunopharmacol. 2016 May;34:146-154. doi: 10.1016/j.intimp.2016.02.030. Epub 2016 Mar 4.

PMID:
26945833
5.

Analysis of Glioblastoma Patients' Plasma Revealed the Presence of MicroRNAs with a Prognostic Impact on Survival and Those of Viral Origin.

Herman A, Gruden K, Blejec A, Podpečan V, Motaln H, Rožman P, Hren M, Zupančič K, Veber M, Verbovšek U, Lah Turnšek T, Porčnik A, Koršič M, Knežević M, Jeras M.

PLoS One. 2015 May 7;10(5):e0125791. doi: 10.1371/journal.pone.0125791. eCollection 2015.

6.

Development and bioevaluation of nanofibers with blood-derived growth factors for dermal wound healing.

Bertoncelj V, Pelipenko J, Kristl J, Jeras M, Cukjati M, Kocbek P.

Eur J Pharm Biopharm. 2014 Sep;88(1):64-74. doi: 10.1016/j.ejpb.2014.06.001. Epub 2014 Jun 12.

PMID:
24931341
7.

Primary human alveolar bone cells isolated from tissue samples acquired at periodontal surgeries exhibit sustained proliferation and retain osteogenic phenotype during in vitro expansion.

Marolt D, Rode M, Kregar-Velikonja N, Jeras M, Knezevic M.

PLoS One. 2014 Mar 25;9(3):e92969. doi: 10.1371/journal.pone.0092969. eCollection 2014.

8.

IFN-γ-rich environment programs dendritic cells toward silencing of cytotoxic immune responses.

Svajger U, Obermajer N, Jeras M.

J Leukoc Biol. 2014 Jan;95(1):33-46. doi: 10.1189/jlb.1112589. Epub 2013 Aug 7.

PMID:
23924658
9.

Osteoimmunology and the influence of pro-inflammatory cytokines on osteoclasts.

Zupan J, Jeras M, Marc J.

Biochem Med (Zagreb). 2013;23(1):43-63. Review.

10.

IFN-γ-induced increase in the mobility of MHC class II compartments in astrocytes depends on intermediate filaments.

Vardjan N, Gabrijel M, Potokar M, Svajger U, Kreft M, Jeras M, de Pablo Y, Faiz M, Pekny M, Zorec R.

J Neuroinflammation. 2012 Jun 26;9:144. doi: 10.1186/1742-2094-9-144.

11.

Anti-inflammatory effects of resveratrol and its potential use in therapy of immune-mediated diseases.

Švajger U, Jeras M.

Int Rev Immunol. 2012 Jun;31(3):202-22. doi: 10.3109/08830185.2012.665108. Review.

PMID:
22587021
12.

A "crossomics" study analysing variability of different components in peripheral blood of healthy caucasoid individuals.

Gruden K, Hren M, Herman A, Blejec A, Albrecht T, Selbig J, Bauer C, Schuchardt J, Or-Guil M, Zupančič K, Svajger U, Stabuc B, Ihan A, Kopitar AN, Ravnikar M, Knežević M, Rožman P, Jeras M.

PLoS One. 2012;7(1):e28761. doi: 10.1371/journal.pone.0028761. Epub 2012 Jan 12.

13.

CNL, a ricin B-like lectin from mushroom Clitocybe nebularis, induces maturation and activation of dendritic cells via the toll-like receptor 4 pathway.

Svajger U, Pohleven J, Kos J, Strukelj B, Jeras M.

Immunology. 2011 Dec;134(4):409-18. doi: 10.1111/j.1365-2567.2011.03500.x.

14.

DC-SIGN ligation greatly affects dendritic cell differentiation from monocytes compromising their normal function.

Svajger U, Obermajer N, Anderluh M, Kos J, Jeras M.

J Leukoc Biol. 2011 Jun;89(6):893-905. doi: 10.1189/jlb.0810463. Epub 2011 Mar 29.

PMID:
21447648
15.

Mechanism of endosomal TLR inhibition by antimalarial drugs and imidazoquinolines.

Kuznik A, Bencina M, Svajger U, Jeras M, Rozman B, Jerala R.

J Immunol. 2011 Apr 15;186(8):4794-804. doi: 10.4049/jimmunol.1000702. Epub 2011 Mar 11.

16.

Optimal dendritic cell differentiation in rpmi media requires the absence of HEPES buffer.

Svajger U, Jeras M.

Immunol Invest. 2011;40(4):413-26. doi: 10.3109/08820139.2011.556172. Epub 2011 Feb 11.

PMID:
21314286
17.

Novel findings in drug-induced dendritic cell tolerogenicity.

Svajger U, Obermajer N, Jeras M.

Int Rev Immunol. 2010 Dec;29(6):574-607. doi: 10.3109/08830185.2010.522280. Review.

PMID:
21073328
18.

An assay for functional dendritic cell-specific ICAM-3-grabbing nonintegrin (DC-SIGN) inhibitors of human dendritic cell adhesion.

Obermajer N, Svajger U, Jeras M, Sattin S, Bernardi A, Anderluh M.

Anal Biochem. 2010 Nov 15;406(2):222-9. doi: 10.1016/j.ab.2010.07.018. Epub 2010 Jul 25.

PMID:
20667443
19.

C-type lectin DC-SIGN: an adhesion, signalling and antigen-uptake molecule that guides dendritic cells in immunity.

Svajger U, Anderluh M, Jeras M, Obermajer N.

Cell Signal. 2010 Oct;22(10):1397-405. doi: 10.1016/j.cellsig.2010.03.018. Epub 2010 Apr 2. Review.

PMID:
20363321
20.

Induction/engineering, detection, selection, and expansion of clinical-grade human antigen-specific CD8 cytotoxic T cell clones for adoptive immunotherapy.

Jeras M, Bricl I, Zorec R, Svajger U.

J Biomed Biotechnol. 2010;2010:705215. doi: 10.1155/2010/705215. Epub 2010 Mar 10. Review.

21.

Regulated exocytosis in astrocytic signal integration.

Parpura V, Baker BJ, Jeras M, Zorec R.

Neurochem Int. 2010 Nov;57(4):451-9. doi: 10.1016/j.neuint.2010.02.007. Epub 2010 Feb 13. Review.

22.

Dendritic cells treated with resveratrol during differentiation from monocytes gain substantial tolerogenic properties upon activation.

Svajger U, Obermajer N, Jeras M.

Immunology. 2010 Apr;129(4):525-35. doi: 10.1111/j.1365-2567.2009.03205.x. Epub 2009 Nov 25.

23.

Review of calciphylaxis and treatment of a severe case after kidney transplantation with iloprost in combination with hyperbaric oxygen and cultured autologous fibrin-based skin substitutes.

Alikadic N, Kovac D, Krasna M, Lindic J, Sabovic M, Tomazic J, Jeras M, Smrke D.

Clin Transplant. 2009 Nov-Dec;23(6):968-74. doi: 10.1111/j.1399-0012.2009.01062.x. Epub 2009 Aug 27.

PMID:
19712088
24.

Fused late endocytic compartments and immunostimulatory capacity of dendritic-tumor cell hybridomas.

Gabrijel M, Bergant M, Kreft M, Jeras M, Zorec R.

J Membr Biol. 2009 May;229(1):11-8. doi: 10.1007/s00232-009-9171-7. Epub 2009 May 6.

PMID:
19418087
25.

Maturation of dendritic cells depends on proteolytic cleavage by cathepsin X.

Obermajer N, Svajger U, Bogyo M, Jeras M, Kos J.

J Leukoc Biol. 2008 Nov;84(5):1306-15. doi: 10.1189/jlb.0508285. Epub 2008 Aug 13.

26.

Niflumic acid renders dendritic cells tolerogenic and up-regulates inhibitory molecules ILT3 and ILT4.

Svajger U, Vidmar A, Jeras M.

Int Immunopharmacol. 2008 Jul;8(7):997-1005. doi: 10.1016/j.intimp.2008.03.006. Epub 2008 Apr 1.

PMID:
18486911
27.

Late dendritic cells are still able to evoke a potent alloreactive CTL response.

Repnik U, Bergant M, Wraber B, Jeras M.

Immunobiology. 2008;213(1):51-64. doi: 10.1016/j.imbio.2007.06.005. Epub 2007 Aug 6.

PMID:
18207027
28.

Platelet gel stimulates proliferation of human dermal fibroblasts in vitro.

Krasna M, Domanović D, Tomsic A, Svajger U, Jeras M.

Acta Dermatovenerol Alp Pannonica Adriat. 2007 Sep;16(3):105-10.

29.

Calcipotriol affects keratinocyte proliferation by decreasing expression of early growth response-1 and polo-like kinase-2.

Kristl J, Slanc P, Krasna M, Berlec A, Jeras M, Strukelj B.

Pharm Res. 2008 Mar;25(3):521-9. Epub 2007 Aug 2.

PMID:
17671831
30.

Preparation of native and amplified tumour RNA for dendritic cell transfection and generation of in vitro anti-tumour CTL responses.

Bergant M, Meden L, Repnik U, Sojar V, Stanisavljević D, Jeras M.

Immunobiology. 2006;211(3):179-89. Epub 2006 Feb 7.

PMID:
16530085
31.
32.

Carboxypeptidases cathepsins X and B display distinct protein profile in human cells and tissues.

Kos J, Sekirnik A, Premzl A, Zavasnik Bergant V, Langerholc T, Turk B, Werle B, Golouh R, Repnik U, Jeras M, Turk V.

Exp Cell Res. 2005 May 15;306(1):103-13.

PMID:
15878337
33.

Differentiation- and maturation-dependent content, localization, and secretion of cystatin C in human dendritic cells.

Zavasnik-Bergant T, Repnik U, Schweiger A, Romih R, Jeras M, Turk V, Kos J.

J Leukoc Biol. 2005 Jul;78(1):122-34. Epub 2005 Apr 13.

PMID:
15829557
34.

Evaluation of a fibrin-based skin substitute prepared in a defined keratinocyte medium.

Krasna M, Planinsek F, Knezevic M, Arnez ZM, Jeras M.

Int J Pharm. 2005 Mar 3;291(1-2):31-7. Epub 2004 Dec 25.

PMID:
15707729
35.

Nucleus pulposus repair with cultured autologous elastic cartilage derived chondrocytes.

Gorensek M, Jaksimović C, Kregar-Velikonja N, Gorensek M, Knezevic M, Jeras M, Pavlovcic V, Cör A.

Cell Mol Biol Lett. 2004;9(2):363-73.

36.

Quantification of cell hybridoma yields with confocal microscopy and flow cytometry.

Gabrijel M, Repnik U, Kreft M, Grilc S, Jeras M, Zorec R.

Biochem Biophys Res Commun. 2004 Feb 13;314(3):717-23.

PMID:
14741694
37.

Simple and cost-effective isolation of monocytes from buffy coats.

Repnik U, Knezevic M, Jeras M.

J Immunol Methods. 2003 Jul;278(1-2):283-92.

PMID:
12957415
38.

An ELISA for the detection of TIMP-1 based on recombinant single chain Fv fusion proteins.

Wozniak G, Obermayr E, Jeras M, Knezevic M, Rüker F.

Clin Chim Acta. 2003 Sep;335(1-2):49-57.

PMID:
12927684
39.

Expression of TIMP-1 in Pichia pastoris. Selection of an anti-TIMP-1 specific single-chain Fv antibody from a large non-immune library.

Wozniak G, Obermayr E, Jeras M, Knezevic M, Rüker F.

Clin Chim Acta. 2003 Jan;327(1-2):171-9.

PMID:
12482633
41.

The outcome of autologous chondrocyte transplantation treatment of cartilage lesions in the knee.

Drobnic M, Kregar-Velikonja N, Radosavljevic D, Gorensek M, Koritnik B, Malicev E, Wozniak G, Jeras M, Knezevic M.

Cell Mol Biol Lett. 2002;7(2):361-3.

PMID:
12097986
42.
43.

Protein synthesis of human articular chondrocytes cultured in vitro for autologous transplantation.

Velikonja NK, Wozniak G, Malicev E, Knezević M, Jeras M.

Pflugers Arch. 2001;442(6 Suppl 1):R169-70.

PMID:
11678327
44.

Immunogenicity of dendritic cells pulsed with cartilage derived soluble alloantigens.

Malicev E, Knezević M, Jeras M.

Pflugers Arch. 2001;442(6 Suppl 1):R165-6.

PMID:
11678325
45.

The contribution of HLA-Class II antigens in humoral non-response and delayed response to HBsAG vaccination.

Vidan-Jeras B, Brinovec V, Jurca B, Levicnik Steyinar S, Jeras M, Bohinjec M.

Pflugers Arch. 2000;440(5 Suppl):R188-9.

PMID:
11005666
46.

In vitro functional tests for evaluation of stimulating capacity of cultured human dendritic cells.

Hajdinjak T, Jeras M, Knezević M, Stabuc B.

Pflugers Arch. 2000;440(5 Suppl):R49-50.

PMID:
11005609
47.

Vitamin C induced apoptosis in human articular chondrocytes.

Malicev E, Woyniak G, Knezevic M, Radosavljević D, Jeras M.

Pflugers Arch. 2000;440(5 Suppl):R46-8.

PMID:
11005608
49.

Possible influence of genes located on chromosome 6 within or near to the major histocompatibility complex on development of essential hypertension.

Vidan-Jeras B, Gregoric A, Jurca B, Jeras M, Bohinjec M.

Pflugers Arch. 2000;439(3 Suppl):R60-2.

PMID:
10653144
50.

Supplemental Content

Support Center